Products
Salathé Capital focus is in structured credit, specifically asset-backed securities and esoteric asset backed securities. We have developed a new esoteric ABS product linking equity performance to an ABS.
CSNs are a brand-new structure for fixed income investors that gives fixed income investors the ability to invest in a collateralized/ABS note to diversify their sources of returns while retaining important fixed income investment characteristics (principal protection and coupon payments) but also providing access to upside in the equity markets.
Salathé expects to issue and manage $1+ billion of CSNs annually. Salathé Capital will provide portfolio management solutions for the CSN’s and participate in any upside alongside our investors, thus aligning our interest with those of our investors.
Management believes it can reasonably achieve $5 – $6+ billion of AUM in ~5 - 7 years from the initial issuance date.
Over time, we expect to expand into adjacent products such as CLOs, Private Credit Lending and CMBS.